Skip to main content
Log in

The Use of α-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal Absorption

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

α-Aminoboronic acid derivatives, potent and reversible inhibitors of aminopeptidases, were tested nasally in situ in rats for stabilizing externally administered peptides. These inhibitors, at nanomolar concentrations, were found to inhibit greatly the degradation of the model peptide, leucine-enkephalin (Leu-enk), in the nasal perfusate. Enzyme inhibition was greater with boroleucine and borovaline than that observed with boroalanine. Boroleucine was more than 100 times more effective in enzyme inhibition than bestatin and more than 1000 times more effective than puromycin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. S. T. Anik, G. McRae, C. Nerenberg, A. Worden, J. Foreman, J. Hwang, S. Kushinsky, R. E. Jones, and B. Vickery. J. Pharm. Sci. 73:684–685 (1984).

    Google Scholar 

  2. A. C. Moses, G. S. Gordon, M. C. Carey, and J. S. Flier. Diabetes 32:1040–1047 (1983).

    Google Scholar 

  3. M. Ishida, Y. Machida, N. Nambu, and T. Nagai. Chem. Pharm. Bull. 29:810–816 (1981).

    Google Scholar 

  4. T. Nishihata, S. Kim, S. Morishita, A. Kamada, N. Yata, and T. Higuchi. J. Pharm. Sci. 72:280–285 (1983).

    Google Scholar 

  5. S. Yoshioka, L. Caldwell, and T. Higuchi. J. Pharm. Sci. 71:593–594 (1982).

    Google Scholar 

  6. H. Okada, I. Yamazaki, Y. Ogawa, S. Hirai, T. Yoshiki, and H. J. Mima. J. Pharm. Sci. 71:1367–1371 (1982).

    Google Scholar 

  7. S. Hirai, T. Ikenaga, and T. Matsuzawa. Diabetes 27:296–299 (1978).

    Google Scholar 

  8. S. Hirai, T. Yashiki, and H. Mima. Int. J. Pharm. 9:173–184 (1981).

    Google Scholar 

  9. S. Hirai, T. Yashiki, and H. Mima. Int. J. Pharm. 9:165–172 (1981).

    Google Scholar 

  10. A. Hussain, J. Faraj, A. Yukihiko, and J. E. Truelove. Biochem. Biophys. Res. Commun. 133:923–928 (1985).

    Google Scholar 

  11. R. E. Stratford, Jr., and V. H. L. Lee. Int. J. Pharm. 30:73–82 (1986).

    Google Scholar 

  12. K. A. Koehler and G. E. Leinhard. Biochemistry 10:2477–2483 (1971).

    Google Scholar 

  13. M. Philipp and M. L. Bender. Proc. Natl. Acad. Sci. USA 68:478–480 (1971).

    Google Scholar 

  14. A. B. Shenvi. Biochemistry 25:1286–1291 (1986).

    Google Scholar 

  15. H. Suda, T. Aoyagi, T. Takeuchi, and H. Umezawa. Arch. Biochem. Biophys. 177:196–200 (1976).

    Google Scholar 

  16. J. K. McDonald, T. J. Reilly, and S. Ellis. Biochem. Biophys. Res. Commun. 16:135–140 (1964).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussain, M.A., Shenvi, A.B., Rowe, S.M. et al. The Use of α-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal Absorption. Pharm Res 6, 186–189 (1989). https://doi.org/10.1023/A:1015949013644

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015949013644

Navigation